BioSpace News Archive

BeyondSpring Inc., a global biopharmaceutical company focused on developing innovative immuno-oncology cancer therapies to transform the lives of patients with unmet medical needs, announced that management will provide a corporate overview at the Jefferies London Healthcare Conference on November 17th.

Conference Call and Live Audio Webcast Scheduled for Monday, November 16, 2020, at 10:00 a.m. ET.

MindMed (NEO: MMED) (OTCQB: MMEDF), a leading psychedelic medicine biotech company, has announced its third quarter financial results for the three and nine months ended September 30, 2020.

Tarsus Pharmaceuticals, Inc. (“Tarsus” NASDAQ: TARS), a late clinical-stage biopharmaceutical company whose mission is to discover and deliver breakthrough treatments to transform the lives of patients with common and poorly treated diseases, starting with the eye, today announced that Bobak Azamian, M.D., Ph.D., CEO of Tarsus, will present an overview of the company at the Jefferies Virtual London Healthcare Conference

Digirad Corporation (Nasdaq: DRAD; DRADP) (“Digirad” or the “Company”), a diversified holding company with three divisions: Healthcare, Building & Construction, and Real Estate & Investments, today announced that its management team will participate at the following investors conferences: November 17: Craig-Hallum Alpha Select Virtual Conference November 18: The Benchmark Company Discovery One on One Virtual Investor Conference Digi

Vifor Pharma today presented the full results from the AFFIRM-AHF study at the 2020 American Heart Association (AHA) Scientific Sessions virtual congress. Simultaneously, results were published in the peer-reviewed medical journal The Lancet.

Swiftarc Ventures, LLC an early and growth stage Venture Capital Firm focused on the next generation of Consumer and Consumer Health disruptors, has made its first portfolio investment in biosafety startup R-Zero, which reduces the spread of infectious diseases through their initial product, “Arc”, a hospital-grade UV-C disinfecting device designed for commercial use including restaurants, hotels, offices, and schools.

Imbed Biosciences, Inc. (Imbed), a privately held biotech company emerging as a leader in advanced wound care, announced today the results of a first prospective clinical evaluation of its next-generation wound dressing, Microlyte® Matrix, in complex chronic wounds.

Cullinan Oncology is proud to announce that its Chief Medical Officer, Jon Wigginton MD, has been honored by the Society for Immunotherapy of Cancer as a recipient of its 2020 Visionary Legacy Award.

Topcon Healthcare, a leading provider of medical devices and software solutions for the global eye care community, announced that it had launched the revolutionary Chronos Automated Binocular Refraction System with SightPilot® guided refraction software.